Skip to content

Supplement Formula Development and Confidentiality: OEM Customer Q&A

April 30, 2026
Supplement Formula Development and Confidentiality: OEM Customer Q&A

For brands, the formula is the core asset. When choosing a one-stop supplement OEM, R&D capability and confidentiality mechanisms are critical. This Q&A walks through the key considerations.

Q1: How do OEMs help with formula R&D?

A one-stop OEM typically maintains its own R&D team and ingredient database, helping clients develop or optimise formulas based on target efficacy, audience, budget and market regulations. Clients can choose pure OEM or full-service ODM models.

Learn more about the full service scope in What is One-Stop Supplement OEM?.

Q2: Will my formula be shared with the factory or other clients?

ACC Biotech enforces strict NDAs. Client formulas remain the brand owner’s property and are never reused, transferred or shared with other clients. All formula documents and sourcing records are archived under controlled access.

Q3: What should an NDA cover?

  • Formula, ingredient suppliers and process details all included in confidentiality scope
  • Clear confidentiality duration and breach liabilities
  • Confidentiality obligations remain after the partnership ends
  • IP ownership of the formula clearly assigned

Q4: How do I assess a factory’s R&D capability?

Evaluate the R&D team background, lab equipment, past projects and certification level. Feel free to explore our equipment and international certifications.

Q5: How is R&D fee calculated?

Typically split into formula development, sample trial production and mass-production transition fees. See Supplement OEM Pricing & Hidden Costs FAQ. For a tailored quote, contact ACC Biotech.